ORIGINAL RESEARCH article
Front. Oncol., 17 February 2023
Sec. Cancer Imaging and Image-directed Interventions
Volume 13 - 2023 | https://doi.org/10.3389/fonc.2023.1095362
RETRACTED: The efficacy and adverse effects of anlotinib in the treatment of high-grade glioma: A retrospective analysis
- FS
Fangcheng Shen â€
- JL
Jing Li â€
- FL
Feng Liu
- NS
Ni Sun
- XQ
XiangNan Qiu
- WD
Wei Ding * ‡
- XS
XiangDong Sun * ‡
Radiotherapy Department, Nanjing JinLing Hospital, Xuanwu District, Nanjing, Jiangsu, China
Summary
Citation
Shen F, Li J, Liu F, Sun N, Qiu X, Ding W and Sun X (2023) RETRACTED: The efficacy and adverse effects of anlotinib in the treatment of high-grade glioma: A retrospective analysis. Front. Oncol. 13:1095362. doi: 10.3389/fonc.2023.1095362
Received
11 November 2022
Accepted
19 January 2023
Published
17 February 2023
Volume
13 - 2023
Edited by
Min Tang, Jiangsu University, China
Reviewed by
Chen Li, Free University of Berlin, Germany; Jichang Han, Washington University in St. Louis, United States
Updates
†These authors have contributed equally to this work and share first authorship
‡These authors have contributed equally to this work
This article was submitted to Cancer Imaging and Image-directed Interventions, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.